🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Non-obstructive Hypertrophic Cardiomyopathy

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy NCT05569382Phase 44 sites📍 Aarhus N📍 Odense📍 Roskilde Morten Steen Kvistholm Jensen · Tests: Verapamil, Bisoprolol, Placebo DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies NCT04265040n/a1 site📍 Heidelberg University Hospital Heidelberg ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy NCT06580717Phase 41 site📍 Seoul Yonsei University · Tests: enavogliflozin 0.3mg, enavogliflozin Placebo Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy NCT05818605NA1 site📍 San Francisco University of California, San Francisco · Tests: Moderate Intensity Exercise Program Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy NCT06433050EARLY Phase 11 site📍 Philadelphia University of Pennsylvania · Tests: Sotagliflozin Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001 NCT07867288Phase 12 sites📍 Boston📍 Kansas City Haya Therapeutics, Inc. · Tests: HTX-001 A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy NCT07023614Phase 276 sites📍 La Jolla📍 Los Angeles📍 San Francisco Imbria Pharmaceuticals, Inc. · Tests: Ninerafaxstat 200mg MR, Placebo Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy NCT07721025Phase 21 site📍 Tampa Lexeo Therapeutics · Tests: LX2006, Usual Care Study of the Progression of Chronic Cardiovascular Conditions NCT07420907n/a1 site📍 Chicago Prolaio Exercise Prescription in Children With Hypertrophic Cardiomyopathy NCT07595354NA1 site📍 Liverpool Alder Hey Children's NHS Foundation Trust · Tests: Exercise Prescription
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy